table of content
1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Global Viral Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Viral Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Viral Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Viral Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Viral Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Viral Vaccines Sales in Volume for the Year 2017-2028
1.4 Viral Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Viral Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Viral Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Viral Vaccines Market Dynamics
1.5.1 Viral Vaccines Industry Trends
1.5.2 Viral Vaccines Market Drivers
1.5.3 Viral Vaccines Market Challenges
1.5.4 Viral Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Viral Vaccines Market Segment by Type
2.1.1 Attenuated Vaccine
2.1.2 Inactivated Vaccine
2.2 Global Viral Vaccines Market Size by Type
2.2.1 Global Viral Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Viral Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Viral Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Viral Vaccines Market Size by Type
2.3.1 United States Viral Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Viral Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Viral Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Viral Vaccines Market Segment by Application
3.1.1 Hospital
3.1.2 Pharmaceutical Factory
3.1.3 Research Institute
3.1.4 Others
3.2 Global Viral Vaccines Market Size by Application
3.2.1 Global Viral Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Viral Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Viral Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Viral Vaccines Market Size by Application
3.3.1 United States Viral Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Viral Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Viral Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Viral Vaccines Competitor Landscape by Company
4.1 Global Viral Vaccines Market Size by Company
4.1.1 Top Global Viral Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Viral Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Viral Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Viral Vaccines Price by Manufacturer (2017-2022)
4.2 Global Viral Vaccines Concentration Ratio (CR)
4.2.1 Viral Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Viral Vaccines in 2021
4.2.3 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Viral Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Viral Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Viral Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Viral Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Viral Vaccines Market Size by Company
4.5.1 Top Viral Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Viral Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Viral Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Viral Vaccines Market Size by Region
5.1 Global Viral Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Viral Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Viral Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Viral Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Viral Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Viral Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Viral Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Viral Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Viral Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Viral Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Viral Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Viral Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Viral Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Viral Vaccines Products Offered
7.1.5 GSK Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Viral Vaccines Products Offered
7.2.5 Merck Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Viral Vaccines Products Offered
7.3.5 Novartis Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Viral Vaccines Products Offered
7.4.5 Pfizer Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Viral Vaccines Products Offered
7.5.5 Sanofi Recent Development
7.6 Bayer
7.6.1 Bayer Corporation Information
7.6.2 Bayer Description and Business Overview
7.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bayer Viral Vaccines Products Offered
7.6.5 Bayer Recent Development
7.7 Zoetis
7.7.1 Zoetis Corporation Information
7.7.2 Zoetis Description and Business Overview
7.7.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Zoetis Viral Vaccines Products Offered
7.7.5 Zoetis Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Corporation Information
7.8.2 AstraZeneca Description and Business Overview
7.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AstraZeneca Viral Vaccines Products Offered
7.8.5 AstraZeneca Recent Development
7.9 Johnson
7.9.1 Johnson Corporation Information
7.9.2 Johnson Description and Business Overview
7.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson Viral Vaccines Products Offered
7.9.5 Johnson Recent Development
7.10 CSL
7.10.1 CSL Corporation Information
7.10.2 CSL Description and Business Overview
7.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 CSL Viral Vaccines Products Offered
7.10.5 CSL Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Viral Vaccines Industry Chain Analysis
8.2 Viral Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Viral Vaccines Distributors
8.3 Viral Vaccines Production Mode & Process
8.4 Viral Vaccines Sales and Marketing
8.4.1 Viral Vaccines Sales Channels
8.4.2 Viral Vaccines Distributors
8.5 Viral Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
